SDMHF News and Press, Sartorius Stedim Biotech

2024-06-11 21:45:00 ET Summary Sartorius AG is a pure play in the bioprocessing industry, dominating the single-use bioreactors market with a focus on upstream flow. Sartorius' strong customer relationships and service-first mentality have led to impressive share gains and consist...

2024-05-27 07:38:31 ET Summary Sartorius AG is facing a temporary setback due to a decline in demand for its products from biopharmaceutical companies. Order intake and book-to-bill ratio suggest a potential recovery in demand, but the strength of the recovery is uncertain. Th...

2024-04-01 09:22:56 ET More on Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript Historical earnings data for Sartorius Stedim Biotech S.A. Dividend scorecard for Sartorius Stedim Biotech S.A. Financial infor...

2024-01-26 15:51:05 ET Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript January 26, 2024 07:00 AM ET Company Participants Dr. Joachim Kreuzburg - IR Rene Faber - Head of Bioprocess Solutions Division & Member Conference Call Participan...

2024-01-26 10:07:59 ET More on Sartorius Stedim Biotech S.A. Historical earnings data for Sartorius Stedim Biotech S.A. Dividend scorecard for Sartorius Stedim Biotech S.A. Financial information for Sartorius Stedim Biotech S.A. Read the full article on See...

2023-12-05 22:50:05 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-11-07 17:07:59 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-10-20 17:03:02 ET Sartorius Stedim Biotech S.A. (SDMHF) Q3 2023 Earnings Conference Call October 20, 2023, 6:30 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financial Officer Rene Faber - Chief Executive Offic...

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...

2023-09-19 10:00:00 ET Summary I am a 24-year-old investor aiming for financial freedom through long-term investing in companies with good management and growth potential. I made changes to the portfolio, buying stocks such as UFP Industries and Ulta Beauty, and selling stocks lik...